Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-31
2010-10-19
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S383000, C514S392000, C548S262600, C548S300100, C548S251000
Reexamination Certificate
active
07816387
ABSTRACT:
The present invention relates to a compound of the formula (1):wherein R1is group of the formula (2):(wherein X is nitrogen atom or C(R5), Y is nitrogen atom or C(R6), R5and R6are each independently hydrogen atom, etc.) etc., m is 1 to 6, L1is single bond, etc., R2is hydrogen atom, substituted or unsubstituted alkyl group, etc., R3is hydrogen atom, etc., L2is single bond, etc., R4is hydrogen atom, substituted or unsubstituted aryl group, etc., or pharmaceutically acceptable salt thereof, being useful for preventing or treating Alzheimer's disease.
REFERENCES:
patent: 2004/0209925 (2004-10-01), Pulley et al.
patent: 2005/0075327 (2005-04-01), Flohr et al.
patent: 2007/0004637 (2007-01-01), Kiso
patent: WO-01/00665 (2001-01-01), None
patent: WO-2004/043916 (2004-05-01), None
patent: WO-2004/050609 (2004-06-01), None
patent: WO-2004/076478 (2004-09-01), None
patent: WO-2004/080376 (2004-09-01), None
patent: WO-2005/040126 (2005-05-01), None
patent: WO-2006/036664 (2006-04-01), None
Neurotherapeutics, 5(3), pp. 399-408 (2008).
Sinha, Sukanto et al., “Purification and cloning of amyloid precursor protein β-secretase from human brain”,Nature, Dec. 2, 1999, vol. 402, pp. 537-540.
Ghosh, Arun K. et al., “Design of potent inhibitors for human brain memapsin 2 (β- secretase)”,J. Am. Chem. Soc., 2000, vol. 122, pp. 3522-3523.
Kimura, Tooru et al., “KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine”,Bioorganic&Medicinal Chemistry Letters, 2004, vol. 14, pp. 1527-1531.
Kimura, Tooru et al., “Design and synthesis of highly active Alzheimer's β-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability”,Bioorganic&Medical Chemistry Letters, 2005, vol. 15, pp. 211-215.
Kinomura Naoya
Kiso Yoshiaki
Mimoto Tsutomu
Nojima Satoshi
Barker Michael
Birch & Stewart Kolasch & Birch, LLP
Dainippon Sumitomo Pharma Co. ,Ltd.
Kiso Yoshiaki
Saeed Kamal A
LandOfFree
β secretase inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β secretase inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β secretase inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4224964